Prevention and treatment of postsurgical head and neck infections

Current Infectious Disease Reports

Volumn 6, Issue 3, 2004, Pages 172-180

  Fraioli, Rebecca ^b   Johnson, Jonas T ^a  

^a University of Pittsburgh School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CLINDAMYCIN; INSULIN; LIDOCAINE; METICILLIN; PENICILLIN G; PLACEBO; SULTAMICILLIN; TIMENTIN; TOPICAL AGENT; VANCOMYCIN;

ALCOHOL CONSUMPTION; ANTIBIOTIC PROPHYLAXIS; BACTERIAL SUPERINFECTION; BACTERIUM CONTAMINATION; CANCER RADIOTHERAPY; CLINICAL TRIAL; HEAD AND NECK INFECTION; HUMAN; INFECTION RISK; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MOUTH FLORA; NEPHROTOXICITY; OTOTOXICITY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; RADIOTHERAPY; REVIEW; RISK FACTOR; SMOKING; SURGICAL INFECTION; SURGICAL TECHNIQUE; WOUND INFECTION;

EID: 3142626681     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0005-6     Document Type: Review

References (75)

1. Johnson J: Postoperative Infection. In Complications in Head and Neck Surgery. Edited by Eisele DW. St. Louis: Mosby; 1993:39-45.
2. Garner J, Hughes J, Davis B: CDC guideline for prevention of surgical wound infections, 1985. Infect Control Hosp Epidemiol 1986, 7:193-200.
3. Mandell-Brown M, Johnson JT, Wagner RL: Cost-effectiveness of prophylactic antibiotics in head and neck surgery. Otolaryngol Head Neck Surg 1984, 92:520-523.
4. Blair EA, Johnson JT, Wagner RL, et al.: Cost analysis of antibiotic prophylaxis in clean head and neck surgery. Arch Otolaryngol Head Neck Surg 1995, 121:269-271.
5. Haley RW, Culver DH, Morgan WM, et al.: Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985, 121:206-215.
6. Bartlett JG, Gorbach SL: Anaerobic infections of the head and neck. Otolaryngol Clin North Am 1976, 9:655-678.
7. Johnson JT, Yu VL, Myers EN, et al.: Efficacy of two third-generation cephalosporins in prophylaxis for head and neck surgery. Arch Otolaryngol 1984, 110:224-227.
8. Dor P, Klastersky J: Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (a double-blind study). Laryngoscope 1973, 83:1992-1998.
9. Goode RL, Abramson N, Fee WE, Levine P, et al.: Effect of prophylactic antibiotics in radical head and neck surgery. Laryngoscope 1979, 89:601-608.
10. Mangram AJ, Horan TC, Pearson ML, et al.: Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999, 27:97-132; quiz 133-134; discussion 96.
11. Johnson JT, Wagner RL: Infection following uncontaminated head and neck surgery. Arch Otolaryngol Head Neck Surg 1987, 113:368-369.
12. Becker GD, Parell GJ: Cefazolin prophylaxis in head and neck cancer surgery. Ann Otol Rhinol Laryngol 1979, 88:183-186.
13. Johnson JT, Myers EN, Thearle PB, et al.: Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984, 94:46-51.
14. Becker GD: Identification and management of the patient at high risk for wound infection. Head Neck Surg 1986, 8:205-210.
15. Velanovich V: A meta-analysis of prophylactic antibiotics in head and neck surgery. Plast Reconstr Surg 1991, 87:429-434; discussion 435.
16. Brown BM, Johnson JT, Wagner RL: Etiologic factors in head and neck wound infections. Laryngoscope 1987, 97:587-590.
17. Newman RK, Weiland FL, Johnson JT, et al.: Salivary scan after major ablative head and neck surgery with prediction of postoperative fistulization. Ann Otol Rhinol Laryngol 1983, 92:366-368.
18. Johnson JT, Schuller DE, Silver F, et al.: Antibiotic prophylaxis in high-risk head and neck surgery: one-day vs. five-day therapy. Otolaryngol Head Neck Surg 1986, 95:554-557.
19. Righi M, Manfredi R, Farneti G, et al.: Short-term versus long-term antimicrobial prophylaxis in oncologic head and neck surgery. Head Neck 1996, 18:399-404.
20. Fee WE Jr, Glenn M, Handen C, Hopp ML: One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Laryngoscope 1984, 94:612-614.
21. Johnson JT, Wagner RL, Schuller DE, et al.: Prophylactic antibiotics for head and neck surgery with flap reconstruction. Arch Otolaryngol Head Neck Surg 1992, 118:488-490.
22. Carroll WR, Rosenstiel D, Fix JR, et al.: Three-dose vs extended-course clindamycin prophylaxis for free-flap reconstruction of the head and neck. Arch Otolaryngol Head Neck Surg 2003, 129:771-774.
23. Bengtson BP, Schusterman MA, Baldwin BJ, et al.: Influence of prior radiotherapy on the development of postoperative complications and success of free tissue transfers in head and neck cancer reconstruction. Am J Surg 1993, 166:326-330.
24. Leach J: Proper handling of soft tissue in the acute phase. Facial Plast Surg 2001, 17:227-238.
25. Hopf HW, Hunt TK, West JM, et al.: Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997, 132:997-1004; discussion 1005.
26. Allen DB, Maguire JJ, Mahdavian M, et al.: Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997, 132:991-996.
27. Greif R, Akca O, Horn EP, et al.: Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group. N Engl J Med 2000, 342:161-167.
28. Heppenstall RB, Goodwin CW, Brighton CT: Fracture healing in the presence of chronic hypoxia. J Bone Joint Surg Am 1976, 58:1153-1156.
29. Jonsson K, Hunt TK, Mathes SJ: Oxygen as an isolated variable influences resistance to infection. Ann Surg 1988, 208:783-787.
30. Kurz A, Sessler DI, Lenhardt R: Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med 1996, 334:1209-1215.
31. Akca O, Melischek M, Scheck T et al.: Postoperative pain and subcutaneous oxygen tension. Lancet 1999, 354:41-42.
32. Robbins KT, Favrot S, Hanna D, Cole R: Risk of wound infection in patients with head and neck cancer. Head Neck 1990, 12:143-148.
33. Cole RR, Robbins KT, Cohen JI, Wolf PF: A predictive model for wound sepsis in oncologic surgery of the head and neck. Otolaryngol Head Neck Surg 1987, 96:165-171.
34. Malone DL, Genuit T, Tracy JK, et al.: Surgical site infections: reanalysis of risk factors. J Surg Res 2002, 103:89-95.
35. Trick WE, Scheckler WE, Tokars JI, et al.: Risk factors for radial artery harvest site infection following coronary artery bypass graft surgery. Clin Infect Dis 2000, 30:270-275.
36. Zerr KJ, Furnary AP, Grunkemeier GL, et al.: Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997, 63:356-361.
37. Brookes GB: Nutritional status - a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg 1985, 93:69-74.
38. Bertrand PC, Piquet MA, Bordier I, et al.: Preoperative nutritional support at home in head and neck cancer patients: from nutritional benefits to the prevention of the alcohol withdrawal syndrome. Curr Opin Clin Nutr Metab Care 2002, 5:435-440.
39. Johns ME: The nutrition problem in head and neck cancer. Otolaryngol Head Neck Surg 1980, 88:691-694.
40. Copeland EM 3rd, Daly JM, Dudrick SJ: Nutritional concepts in the treatment of head and neck malignancies. Head Neck Surg 1979, 1:350-365.
41. Daly JM, Dudrick SJ, Copeland EM 3rd: Parenteral nutrition in patients with head and neck cancer: techniques and results. Otolaryngol Head Neck Surg 1980, 88:707-713.
42. Close LG: Indications for hyperalimentation in the treatment of head and neck malignancies. Otolaryngol Head Neck Surg 1980, 88:701-706.
43. Tonnesen H, Peterson KR, Hojgaard L, et al.: Postoperative morbidity among symptom-free alcohol misusers. Lancet 1992, 340:334-337.
44. Jorgensen LN, Kallehave F, Christensen E, et al.: Less collagen production in smokers. Surgery 1998, 123:450-455.
45. Sorensen LT, Karlsmark T, Gottrup F: Abstinence from smoking reduces incisional wound infection: a randomized controlled trial. Ann Surg 2003, 238:1-5.
46. Moller AM, Villebro N, Pedersen T, Tonnesen H: Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002, 359:114-117.
47. Sorensen LT, Horby J, Friis E, et al.: Smoking as a risk factor for wound healing and infection in breast cancer surgery. Eur J Surg Oncol 2002, 28:815-820.
48. Johnson JT, Bloomer WB: Effect of prior radiotherapy on post-surgical wound infection. Head Neck 1989, 11:132-136.
49. Soylu L, Kiroglu M, Aydogan B, et al.: Pharyngocutaneous fistula following laryngectomy. Head Neck 1998, 20:22-25.
50. Becker G, Parell C: The non-value of preoperative and intraoperative cultures in predicting the bacteriology of subsequent wound infection in patients undergoing major head and neck cancer surgery. Laryngoscope 1980, 90:1933-1940.
51. Bumpous JM, Johnson JT: The infected wound and its management. Otolaryngol Clin North Am 1995, 28:987-1001.
52. Johnson JT, Kachman K, Wagner RL, Myers EN: Comparison of ampicillin/sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgery. Head Neck 1997, 19:367-371.
53. Rodrigo JP, Alvarez JC, Gomez JR, et al.: Comparison of three prophylactic antibiotic regimens in clean-contaminated head and neck surgery. Head Neck 1997, 19:188-193.
54. Johnson JT, Yu VL, Myers EN, et al.: Cefazolin vs moxalactam? A double-blind randomized trial of cephalosporins in head and neck surgery. Arch Otolaryngol Head Neck Surg 1986, 112:151-153.
55. Rubin J, Johnson JT, Wagner RL, Yu VL: Bacteriologic analysis of wound infection following major head and neck surgery. Arch Otolaryngol Head Neck Surg 1988, 114:969-972.
56. Weber RS, Raad I, Frankenthaler R, et al.: Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage. Arch Otolaryngol Head Neck Surg 1992, 118:1159-1163.
57. Johnson JT, Yu VL: Role of aerobic gram-negative rods, anaerobes, and fungi in wound infection after head and neck surgery: implications for antibiotic prophylaxis. Head Neck 1989, 11:27-29.
58. Johnson JT, Yu VL: Antibiotic use during major head and neck surgery. Ann Surg 1988, 207:108-111.
59. Johnson JT, Yu VL, Myers EN, Wagner RL: An assessment of the need for gram-negative bacterial coverage in antibiotic prophylaxis for oncological head and neck surgery. J Infect Dis 1987, 155:331-333.
60. Burke JF: The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961, 50:161-168.
61. Classen DC, Evans RS, Pestotnik SL, et al.: The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992, 326:281-286.
62. Mustafa E, Tahsin A: Cefotaxime prophylaxis in major non-contaminated head and neck surgery: one-day vs. seven-day therapy. J Laryngol Otol 1993, 107:30-32.
63. Carrau RL, Snyderman C, Janecka IP, et al.: Antibiotic prophylaxis in cranial base surgery. Head Neck 1991, 13:311-317.
64. Kirchner JC, Edberg SC, Sasaki CT: The use of topical oral antibiotics in head and neck prophylaxis: is it justified? Laryngoscope 1988, 98:26-29.
65. Elledge ES, Whiddon RG Jr, Fraker JT, Stambaugh KI: The effects of topical oral clindamycin antibiotic rinses on the bacterial content of saliva on healthy human subjects. Otolaryngol Head Neck Surg 1991, 105:836-839.
66. Grandis JR, Vickers RM, Ribs JD, et al.: The efficacy of topical antibiotic prophylaxis for contaminated head and neck surgery. Laryngoscope 1994, 104:719-724.
67. Simons JP, Johnson JT, Yu VL, et al.: The role of topical antibiotic prophylaxis in patients undergoing contaminated head and neck surgery with flap reconstruction. Laryngoscope 2001, 111:329-335.
68. Johnson JT: Principles of antibiotic prophylaxis. In Infectious Diseases and Antimicrobial Therapy of the Ears, Nose, and Throat. Edited by Johnson JT and Yu VL. Philadelphia: WB Saunders Company; 1997:589-593.
69. Burke JF: Preventing bacterial infection by coordinating antibiotic and host activity: a time-dependent relationship. South Med J 1977, 70(Suppl 1):24-26.
70. Wittmann DH, Schein M: Let us shorten antibiotic prophylaxis and therapy in surgery. Am J Surg 1996, 172:26S-32S.
71. Yee J, Dixon CM, McLean AP, Meakins JL: Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Arch Surg 1991, 126:241-246.
72. Dallal RM, Harbrecht BG, Boujoukas AJ, et al.: Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002, 235:363-372.
73. Griebie M, Adams GL: Clostridium difficile colitis following head and neck surgery. Report of cases. Arch Otolaryngol 1985, 111:550-553.
74. Johnson J, Myers E: Management of complications of head and neck surgery. In Cancer of the Head and Neck. Edited by Myers E, Suen JY. Philadelphia: WB Saunders Company; 1996:693-711.
75. Becker GD: Ineffectiveness of closed suction drainage cultures in the prediction of bacteriologic findings in wound infections in patients undergoing contaminated head and neck cancer surgery. Otolaryngol Head Neck Surg 1985, 93:743-747.